X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pharmacotherapy (1276) 1276
medicine & public health (1205) 1205
index medicus (1025) 1025
humans (1002) 1002
pharmacology/toxicology (987) 987
internal medicine (970) 970
pharmacology & pharmacy (844) 844
adis drug profiles (727) 727
toxicology (528) 528
pharmacokinetics (321) 321
adis drug evaluations (299) 299
clinical trials as topic (298) 298
drug therapy (285) 285
research and development (270) 270
randomized controlled trials as topic (237) 237
treatment outcome (233) 233
therapeutic use (224) 224
animals (221) 221
pharmacodynamics (207) 207
dosage and administration (200) 200
double-blind (187) 187
tolerability (161) 161
adis r and d profiles (151) 151
psychiatry (149) 149
research (141) 141
adis-drug-profiles (138) 138
neurosciences (138) 138
neurology (136) 136
psychopharmacology (136) 136
efficacy (135) 135
health aspects (122) 122
complications and side effects (119) 119
female (117) 117
adult (109) 109
clinical neurology (103) 103
adis-drug-evaluations (102) 102
pharmacy (99) 99
safety (96) 96
dose-response relationship, drug (89) 89
drug therapy, combination (87) 87
antibodies (84) 84
biomedicine (80) 80
cancer research (80) 80
molecular medicine (80) 80
management (78) 78
antineoplastic agents - therapeutic use (76) 76
drug administration schedule (76) 76
oncology (76) 76
immunology (75) 75
children (73) 73
male (73) 73
patient outcomes (72) 72
administration, oral (68) 68
quality of life (68) 68
drug interactions (67) 67
quality-of-life (65) 65
trial (61) 61
drug combinations (60) 60
usage (60) 60
care and treatment (59) 59
controlled release drugs (59) 59
antibodies, monoclonal - therapeutic use (58) 58
cost-effectiveness (58) 58
child (57) 57
pediatrics (57) 57
adolescent (56) 56
geriatrics/gerontology (56) 56
therapy (56) 56
antineoplastic agents - adverse effects (55) 55
adis spotlights (54) 54
hypertension (52) 52
geriatrics & gerontology (50) 50
pharmacoeconomics (50) 50
delayed-action preparations (49) 49
aged (48) 48
prevention (48) 48
clinical trials, phase iii as topic (47) 47
diagnosis (47) 47
placebo-controlled trial (46) 46
half-life (44) 44
middle aged (44) 44
adolescents (43) 43
area under curve (43) 43
clinical trials (42) 42
diabetes mellitus, type 2 - drug therapy (41) 41
cancer (40) 40
hypertension - drug therapy (40) 40
type 2 diabetes mellitus (40) 40
antibodies, monoclonal, humanized (38) 38
cardiology (38) 38
drugs, investigational - therapeutic use (38) 38
cost-benefit analysis (37) 37
in-vitro (37) 37
antihypertensive agents - therapeutic use (36) 36
antineoplastic agents - pharmacokinetics (36) 36
hiv infections (36) 36
pharmacology (36) 36
randomized controlled-trial (36) 36
drugs (35) 35
hiv infections - drug therapy (35) 35
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Drugs, ISSN 0012-6667, 2010, Volume 70, Issue 12, pp. 1603 - 1613
Journal Article
Drugs, ISSN 0012-6667, 2012, Volume 72, Issue 9, pp. 1229 - 1241
Journal Article
Drugs, ISSN 0012-6667, 2012, Volume 72, Issue 2, p. 192
Journal Article
Drugs, ISSN 0012-6667, 2012, Volume 72, Issue 11, pp. 1543 - 1557
Journal Article
Drugs, ISSN 0012-6667, 2010, Volume 70, Issue 14, pp. 1819 - 1829
Journal Article
Pediatric Drugs, ISSN 1174-5878, 2012, Volume 14, Issue 6, pp. 417 - 427
Journal Article
Drugs and Aging, ISSN 1170-229X, 2010, Volume 27, Issue 7, pp. 597 - 605
Journal Article
Drugs, ISSN 0012-6667, 2008, Volume 68, Issue 12, pp. 1699 - 1709
▴ Dabigatran etexilate is an orally administered prodrug of dabigatran, which is a potent, concentration-dependent inhibitor of thrombus formation and... 
Dabigatran etexilate | Thromboembolism | Research and development | Adis Drug Profiles | Orthopaedic surgery | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Dabigatran etexilate, general | Thromboembolism, prevention | IN-VITRO | DIRECT THROMBIN INHIBITOR | ORTHOPEDIC-SURGERY | KNEE REPLACEMENT | VENOUS THROMBOEMBOLISM | PHARMACOKINETICS | PREVENTION | TOTAL HIP-REPLACEMENT | RANDOMIZED-TRIAL | PHARMACOLOGY & PHARMACY | PHARMACODYNAMICS | TOXICOLOGY | Area Under Curve | Pyridines - chemistry | Humans | Half-Life | Pyridines - pharmacokinetics | Dabigatran | Benzimidazoles - chemistry | Suppuration - chemically induced | Surgical Wound Infection - chemically induced | Molecular Structure | Platelet Aggregation - drug effects | Thromboembolism - drug therapy | Thrombosis - prevention & control | Benzimidazoles - therapeutic use | Pyridines - therapeutic use | Prodrugs | Anemia - chemically induced | Benzimidazoles - pharmacokinetics | Anticoagulants - therapeutic use | Treatment Outcome | Anticoagulants - adverse effects | Randomized Controlled Trials as Topic | Anticoagulants - pharmacokinetics | Thrombosis - drug therapy | Hemorrhage - chemically induced | Complications and side effects | Dosage and administration | Venous thrombosis | Drug therapy | Patient outcomes | Index Medicus
Journal Article
Drugs, ISSN 0012-6667, 2008, Volume 68, Issue 1, pp. 123 - 130
▴ A new formulation of the nonselective NSAID diclofenac sodium suitable for intravenous bolus injection has been developed using hydroxypropyl β-cyclodextrin... 
Postoperative pain | Adis Drug Profiles | Diclofenac
Journal Article
Journal Article
Pediatric Drugs, ISSN 1174-5878, 2012, Volume 14, Issue 3, pp. 201 - 207
Journal Article
Drugs, ISSN 0012-6667, 10/2012, Volume 72, Issue 14, pp. 1917 - 1928
Nomegestrol acetate/estradiol is a combined oral contraceptive with approval in many countries. This fixed-dose combination tablet contains nomegestrol... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Adis-Drug-Profiles | Estradiolnomegestrol | Contraception | Oral-contraceptives | Ethinylestradioldrospirenone | LEVONORGESTREL | EFFICACY | ESTRADIOL | DROSPIRENONE | REGIMEN | PHARMACOLOGY & PHARMACY | TOXICOLOGY | ETHINYLESTRADIOL | ACETATE | CARBOHYDRATE-METABOLISM | 17-BETA-ESTRADIOL | OVARIAN-FUNCTION | Humans | Middle Aged | Norpregnadienes - administration & dosage | Estrogens - adverse effects | Young Adult | Ethinyl Estradiol - adverse effects | Megestrol - administration & dosage | Estrogens - chemistry | Contraceptives, Oral, Combined - chemistry | Megestrol - agonists | Megestrol - chemistry | Estradiol - adverse effects | Adult | Female | Acne Vulgaris - chemically induced | Ethinyl Estradiol - administration & dosage | Menstrual Cycle - drug effects | Contraceptives, Oral, Combined - administration & dosage | Drug Therapy, Combination | Progesterone Congeners - adverse effects | Androstenes - adverse effects | Estradiol - administration & dosage | Androstenes - administration & dosage | Contraceptives, Oral, Combined - adverse effects | Randomized Controlled Trials as Topic | Pregnancy | Estradiol - chemistry | Adolescent | Progesterone Congeners - administration & dosage | Progesterone Congeners - chemistry | Norpregnadienes - chemistry | Estrogens - administration & dosage | Norpregnadienes - agonists | Menstruation disorders | Contraceptives | Dosage and administration | Hormone therapy | Drug therapy | Methods | Index Medicus
Journal Article
American Journal of Clinical Dermatology, ISSN 1175-0561, 06/2010, Volume 11, Issue 3, pp. 217 - 222
Anti-inflammatory dose doxycycline 40 mg capsules (30 mg immediate-release and 10 mg delayed-release beads) provide a sub-antimicrobial dose that reduces the... 
Doxycycline, therapeutic use | Adis-Drug-Profiles | Doxycycline, pharmacodynamics | Doxycycline, pharmacokinetics | Doxycycline, adverse reactions | Rosacea | Adverse reactions | Pharmacodynamics | Doxycycline | Pharmacokinetics | Therapeutic use
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.